Converting-enzyme inhibition and coronary blood flow

F. Magrini, M. Shimizu, N. Roberts, F. M. Fouad, R. C. Tarazi, A. Zanchetti

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The effects of converting-enzyme inhibition (25 mg oral captopril) on coronary hemodynamics in the presence and absence of activation of the renin-angiotensin system were studied in 10 patients with mild essential hypertension with no evidence of ischemic heart disease. Coronary blood flow was determined by thermodilution before and after 1 week of diuretic therapy in six patients and before and after placebo in four patients. The diuretic (50 mg/day furosemide) reduced coronary blood flow and increased coronary vascular resistance; in these same patients, captopril reduced mean arterial pressure and the rate-pressure product but increased coronary flow significantly. There was no change in any of these variables after captopril in the placebo group. Similar results were obtained in normotensive rats treated with hydrochlorothiazide; the increase in coronary flow after captopril correlated significantly with the control plasma renin activity. These results in hypertensive humans and normotensive experimental animals indicate that (1) diuretic therapy reduces coronary blood flow significant, and (2) angiotensin can play a significant role in modulating coronary vascular resistance under conditions associated with activation of the renin-angiotensin system.

Original languageEnglish
JournalCirculation
Volume75
Issue number1 II SUPPL. 1
Publication statusPublished - 1987

Fingerprint

Captopril
Diuretics
Enzymes
Renin-Angiotensin System
Vascular Resistance
Placebos
Thermodilution
Hydrochlorothiazide
Furosemide
Angiotensins
Renin
Myocardial Ischemia
Arterial Pressure
Hemodynamics
Pressure
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Magrini, F., Shimizu, M., Roberts, N., Fouad, F. M., Tarazi, R. C., & Zanchetti, A. (1987). Converting-enzyme inhibition and coronary blood flow. Circulation, 75(1 II SUPPL. 1).

Converting-enzyme inhibition and coronary blood flow. / Magrini, F.; Shimizu, M.; Roberts, N.; Fouad, F. M.; Tarazi, R. C.; Zanchetti, A.

In: Circulation, Vol. 75, No. 1 II SUPPL. 1, 1987.

Research output: Contribution to journalArticle

Magrini, F, Shimizu, M, Roberts, N, Fouad, FM, Tarazi, RC & Zanchetti, A 1987, 'Converting-enzyme inhibition and coronary blood flow', Circulation, vol. 75, no. 1 II SUPPL. 1.
Magrini F, Shimizu M, Roberts N, Fouad FM, Tarazi RC, Zanchetti A. Converting-enzyme inhibition and coronary blood flow. Circulation. 1987;75(1 II SUPPL. 1).
Magrini, F. ; Shimizu, M. ; Roberts, N. ; Fouad, F. M. ; Tarazi, R. C. ; Zanchetti, A. / Converting-enzyme inhibition and coronary blood flow. In: Circulation. 1987 ; Vol. 75, No. 1 II SUPPL. 1.
@article{593eca1e7a374dd996f0db808a6ff162,
title = "Converting-enzyme inhibition and coronary blood flow",
abstract = "The effects of converting-enzyme inhibition (25 mg oral captopril) on coronary hemodynamics in the presence and absence of activation of the renin-angiotensin system were studied in 10 patients with mild essential hypertension with no evidence of ischemic heart disease. Coronary blood flow was determined by thermodilution before and after 1 week of diuretic therapy in six patients and before and after placebo in four patients. The diuretic (50 mg/day furosemide) reduced coronary blood flow and increased coronary vascular resistance; in these same patients, captopril reduced mean arterial pressure and the rate-pressure product but increased coronary flow significantly. There was no change in any of these variables after captopril in the placebo group. Similar results were obtained in normotensive rats treated with hydrochlorothiazide; the increase in coronary flow after captopril correlated significantly with the control plasma renin activity. These results in hypertensive humans and normotensive experimental animals indicate that (1) diuretic therapy reduces coronary blood flow significant, and (2) angiotensin can play a significant role in modulating coronary vascular resistance under conditions associated with activation of the renin-angiotensin system.",
author = "F. Magrini and M. Shimizu and N. Roberts and Fouad, {F. M.} and Tarazi, {R. C.} and A. Zanchetti",
year = "1987",
language = "English",
volume = "75",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1 II SUPPL. 1",

}

TY - JOUR

T1 - Converting-enzyme inhibition and coronary blood flow

AU - Magrini, F.

AU - Shimizu, M.

AU - Roberts, N.

AU - Fouad, F. M.

AU - Tarazi, R. C.

AU - Zanchetti, A.

PY - 1987

Y1 - 1987

N2 - The effects of converting-enzyme inhibition (25 mg oral captopril) on coronary hemodynamics in the presence and absence of activation of the renin-angiotensin system were studied in 10 patients with mild essential hypertension with no evidence of ischemic heart disease. Coronary blood flow was determined by thermodilution before and after 1 week of diuretic therapy in six patients and before and after placebo in four patients. The diuretic (50 mg/day furosemide) reduced coronary blood flow and increased coronary vascular resistance; in these same patients, captopril reduced mean arterial pressure and the rate-pressure product but increased coronary flow significantly. There was no change in any of these variables after captopril in the placebo group. Similar results were obtained in normotensive rats treated with hydrochlorothiazide; the increase in coronary flow after captopril correlated significantly with the control plasma renin activity. These results in hypertensive humans and normotensive experimental animals indicate that (1) diuretic therapy reduces coronary blood flow significant, and (2) angiotensin can play a significant role in modulating coronary vascular resistance under conditions associated with activation of the renin-angiotensin system.

AB - The effects of converting-enzyme inhibition (25 mg oral captopril) on coronary hemodynamics in the presence and absence of activation of the renin-angiotensin system were studied in 10 patients with mild essential hypertension with no evidence of ischemic heart disease. Coronary blood flow was determined by thermodilution before and after 1 week of diuretic therapy in six patients and before and after placebo in four patients. The diuretic (50 mg/day furosemide) reduced coronary blood flow and increased coronary vascular resistance; in these same patients, captopril reduced mean arterial pressure and the rate-pressure product but increased coronary flow significantly. There was no change in any of these variables after captopril in the placebo group. Similar results were obtained in normotensive rats treated with hydrochlorothiazide; the increase in coronary flow after captopril correlated significantly with the control plasma renin activity. These results in hypertensive humans and normotensive experimental animals indicate that (1) diuretic therapy reduces coronary blood flow significant, and (2) angiotensin can play a significant role in modulating coronary vascular resistance under conditions associated with activation of the renin-angiotensin system.

UR - http://www.scopus.com/inward/record.url?scp=0023143717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023143717&partnerID=8YFLogxK

M3 - Article

VL - 75

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1 II SUPPL. 1

ER -